Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and
joint restoration products for hip, knee, shoulder and spine, announced
today that revenue for 2014 increased 5% to $248.4 million from $237.1
million in 2013.
for Exactech 2014 Revenue Up 5% to $248.4 Million, Net Income Up 7% to $16.5 Million, EPS $1.18; Q4 Revenue Up 3% to $63.3M, Net Income Up 11% to $5.1M, EPS $0.36 investment picks